APO Research
Talk to an analyst

APO RESEARCH · REPORT

Drug Testing

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Drug Testing Market Analysis and Forecast 2026-2032

20 December 2025195 pages

Choose your research edition.

Industry ResearchDrug Testing Industry Research Report 2026115 pages · $2,950 USDIndustry Growth & TrendsGlobal Drug Testing Industry Growth and Trends Forecast to 2032100 pages · $3,450 USDMarket StructureGlobal Drug Testing Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032190 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Drug Testing Market Outlook and Growth Opportunities 2026192 pages · $4,250 USDMarket Analysis & ForecastGlobal Drug Testing Market Analysis and Forecast 2026-2032195 pages · $4,950 USD

Market perspective

The global Drug Testing market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The North America market for Drug Testing is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Drug Testing is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Drug Testing is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Drug Testing is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global companies of Drug Testing include Siemens Healthcare, Thermo Fisher Scientific, Roche Diagnostics, Quest Diagnostics, Shimadzu, Quest Diagnostics, Laboratory Corporation of America MPD, KGAA Alere and Express Diagnostics, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

Report Includes

This report presents an overview of global market for Drug Testing, market size. Analyses of the global market trends, with historic market revenue data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Drug Testing, also provides the revenue of main regions and countries. Of the upcoming market potential for Drug Testing, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Drug Testing revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Drug Testing market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2021 to 2032. Evaluation and forecast the market size for Drug Testing revenue, projected growth trends, production technology, application and end-user industry.

Drug Testing Segment by Company

Siemens Healthcare

Thermo Fisher Scientific

Roche Diagnostics

Quest Diagnostics

Shimadzu

Quest Diagnostics

Laboratory Corporation of America MPD

KGAA Alere

Express Diagnostics

Drgerwerk AG & Co.

Drug Testing Segment by Type

Hair Sample

Breath Sample

Oral Fluid

Urine Sample

Others

Drug Testing Segment by Application

Personal Users

Workplace and Schools

Pain Management Centers

Criminal Justice System & Law Enforcement Agencies

Drug Testing Laboratories

Drug Treatment Centers

Hospitals

Drug Testing Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key players, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Drug Testing market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Drug Testing and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in market size), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Drug Testing.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Revenue of Drug Testing in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 4: Detailed analysis of Drug Testing company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Drug Testing revenue, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, revenue for each segment.

Chapter 9: Europe by type, by application and by country, revenue for each segment.

Chapter 10: China type, by application, revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, revenue for each segment.

Chapter 13: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Drug Testing Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Hair Sample Major Player Table 3. Breath Sample Major Player Table 4. Oral Fluid Major Player Table 5. Urine Sample Major Player Table 6. Others Major Player Table 7. Global Drug Testing Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 8. Personal Users Major Player Table 9. Workplace and Schools Major Player Table 10. Pain Management Centers Major Player Table 11. Criminal Justice System & Law Enforcement Agencies Major Player Table 12. Drug Testing Laboratories Major Player Table 13. Drug Treatment Centers Major Player Table 14. Hospitals Major Player Table 15. Drug Testing Industry Trends Table 16. Drug Testing Industry Drivers Table 17. Drug Testing Industry Opportunities and Challenges Table 18. Drug Testing Industry Restraints Table 19. Global Drug Testing Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 20. Global Drug Testing Market Size by Region (2021-2026) & (US$ Million) Table 21. Global Drug Testing Market Share by Region (2021-2026) Table 22. Global Drug Testing Market Size by Region (2027-2032) & (US$ Million) Table 23. Global Drug Testing Market Share by Region (2027-2032) Table 24. Global Drug Testing Revenue by Players (US$ Million) & (2021-2026) Table 25. Global Drug Testing Revenue Market Share by Players (2021-2026) Table 26. Global Drug Testing Key Players Ranking, 2024 VS 2025 VS 2026 Table 27. Global Drug Testing Key Players Headquarters & Area Served Table 28. Global Drug Testing Players, Product Type & Application Table 29. Global Drug Testing Players Establishment Date Table 30. Global Players Market Concentration Ratio (CR5 and HHI) Table 31. Global Drug Testing by Players Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 32. Global Drug Testing Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 33. Global Drug Testing Revenue by Type (2021-2026) & (US$ Million) Table 34. Global Drug Testing Revenue by Type (2027-2032) & (US$ Million) Table 35. Global Drug Testing Revenue Market Share by Type (2021-2026) Table 36. Global Drug Testing Revenue Market Share by Type (2027-2032) Table 37. Global Drug Testing Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 38. Global Drug Testing Revenue by Application (2021-2026) & (US$ Million) Table 39. Global Drug Testing Revenue by Application (2027-2032) & (US$ Million) Table 40. Global Drug Testing Revenue Market Share by Application (2021-2026) Table 41. Global Drug Testing Revenue Market Share by Application (2027-2032) Table 42. Siemens Healthcare Company Information Table 43. Siemens Healthcare Business Overview Table 44. Siemens Healthcare Drug Testing Revenue and Gross Margin (US$ Million) & (2021-2026) Table 45. Siemens Healthcare Drug Testing Product Portfolio Table 46. Siemens Healthcare Recent Development Table 47. Thermo Fisher Scientific Company Information Table 48. Thermo Fisher Scientific Business Overview Table 49. Thermo Fisher Scientific Drug Testing Revenue and Gross Margin (US$ Million) & (2021-2026) Table 50. Thermo Fisher Scientific Drug Testing Product Portfolio Table 51. Thermo Fisher Scientific Recent Development Table 52. Roche Diagnostics Company Information Table 53. Roche Diagnostics Business Overview Table 54. Roche Diagnostics Drug Testing Revenue and Gross Margin (US$ Million) & (2021-2026) Table 55. Roche Diagnostics Drug Testing Product Portfolio Table 56. Roche Diagnostics Recent Development Table 57. Quest Diagnostics Company Information Table 58. Quest Diagnostics Business Overview Table 59. Quest Diagnostics Drug Testing Revenue and Gross Margin (US$ Million) & (2021-2026) Table 60. Quest Diagnostics Drug Testing Product Portfolio Table 61. Quest Diagnostics Recent Development Table 62. Shimadzu Company Information Table 63. Shimadzu Business Overview Table 64. Shimadzu Drug Testing Revenue and Gross Margin (US$ Million) & (2021-2026) Table 65. Shimadzu Drug Testing Product Portfolio Table 66. Shimadzu Recent Development Table 67. Quest Diagnostics Company Information Table 68. Quest Diagnostics Business Overview Table 69. Quest Diagnostics Drug Testing Revenue and Gross Margin (US$ Million) & (2021-2026) Table 70. Quest Diagnostics Drug Testing Product Portfolio Table 71. Quest Diagnostics Recent Development Table 72. Laboratory Corporation of America MPD Company Information Table 73. Laboratory Corporation of America MPD Business Overview Table 74. Laboratory Corporation of America MPD Drug Testing Revenue and Gross Margin (US$ Million) & (2021-2026) Table 75. Laboratory Corporation of America MPD Drug Testing Product Portfolio Table 76. Laboratory Corporation of America MPD Recent Development Table 77. KGAA Alere Company Information Table 78. KGAA Alere Business Overview Table 79. KGAA Alere Drug Testing Revenue and Gross Margin (US$ Million) & (2021-2026) Table 80. KGAA Alere Drug Testing Product Portfolio Table 81. KGAA Alere Recent Development Table 82. Express Diagnostics Company Information Table 83. Express Diagnostics Business Overview Table 84. Express Diagnostics Drug Testing Revenue and Gross Margin (US$ Million) & (2021-2026) Table 85. Express Diagnostics Drug Testing Product Portfolio Table 86. Express Diagnostics Recent Development Table 87. Drgerwerk AG & Co. Company Information Table 88. Drgerwerk AG & Co. Business Overview Table 89. Drgerwerk AG & Co. Drug Testing Revenue and Gross Margin (US$ Million) & (2021-2026) Table 90. Drgerwerk AG & Co. Drug Testing Product Portfolio Table 91. Drgerwerk AG & Co. Recent Development Table 92. North America Drug Testing Revenue by Type (2021-2026) & (US$ Million) Table 93. North America Drug Testing Revenue by Type (2027-2032) & (US$ Million) Table 94. North America Drug Testing Revenue by Application (2021-2026) & (US$ Million) Table 95. North America Drug Testing Revenue by Application (2027-2032) & (US$ Million) Table 96. North America Drug Testing Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 97. North America Drug Testing Revenue by Country (2021-2026) & (US$ Million) Table 98. North America Drug Testing Revenue by Country (US$ Million) & (2027-2032) Table 99. Europe Drug Testing Revenue by Type (2021-2026) & (US$ Million) Table 100. Europe Drug Testing Revenue by Type (2027-2032) & (US$ Million) Table 101. Europe Drug Testing Revenue by Application (2021-2026) & (US$ Million) Table 102. Europe Drug Testing Revenue by Application (2027-2032) & (US$ Million) Table 103. Europe Drug Testing Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 104. Europe Drug Testing Revenue by Country (2021-2026) & (US$ Million) Table 105. Europe Drug Testing Revenue by Country (US$ Million) & (2027-2032) Table 106. China Drug Testing Revenue by Type (2021-2026) & (US$ Million) Table 107. China Drug Testing Revenue by Type (2027-2032) & (US$ Million) Table 108. China Drug Testing Revenue by Application (2021-2026) & (US$ Million) Table 109. China Drug Testing Revenue by Application (2027-2032) & (US$ Million) Table 110. Asia Drug Testing Revenue by Type (2021-2026) & (US$ Million) Table 111. Asia Drug Testing Revenue by Type (2027-2032) & (US$ Million) Table 112. Asia Drug Testing Revenue by Application (2021-2026) & (US$ Million) Table 113. Asia Drug Testing Revenue by Application (2027-2032) & (US$ Million) Table 114. Asia Drug Testing Revenue by Region (2021 VS 2025 VS 2032) & (US$ Million) Table 115. Asia Drug Testing Revenue by Region (US$ Million) & (2021-2026) Table 116. Asia Drug Testing Revenue by Region (US$ Million) & (2027-2032) Table 117. SAMEA Drug Testing Revenue by Type (2021-2026) & (US$ Million) Table 118. SAMEA Drug Testing Revenue by Type (2027-2032) & (US$ Million) Table 119. SAMEA Drug Testing Revenue by Application (2021-2026) & (US$ Million) Table 120. SAMEA Drug Testing Revenue by Application (2027-2032) & (US$ Million) Table 121. SAMEA Drug Testing Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 122. SAMEA Drug Testing Revenue by Country (2021-2026) & (US$ Million) Table 123. SAMEA Drug Testing Revenue by Country (US$ Million) & (2027-2032) Table 124. Research Programs/Design for This Report Table 125. Authors List of This Report Table 126. Secondary Sources Table 127. Primary Sources List of Figures Figure 1. Drug Testing Image Figure 2. Global Drug Testing Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Drug Testing Market Size Share 2021 VS 2025 VS 2032 Figure 4. Hair Sample Image Figure 5. Breath Sample Image Figure 6. Oral Fluid Image Figure 7. Urine Sample Image Figure 8. Others Image Figure 9. Global Drug Testing Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 10. Global Drug Testing Market Size Share 2021 VS 2025 VS 2032 Figure 11. Personal Users Image Figure 12. Workplace and Schools Image Figure 13. Pain Management Centers Image Figure 14. Criminal Justice System & Law Enforcement Agencies Image Figure 15. Drug Testing Laboratories Image Figure 16. Drug Treatment Centers Image Figure 17. Hospitals Image Figure 18. Global Drug Testing Market Size (US$ Million) & (2021-2032) Figure 19. Global Drug Testing Market Size, (US$ Million), 2021 VS 2025 VS 2032 Figure 20. Global Drug Testing Market Share by Region: 2021 VS 2025 VS 2032 Figure 21. Global Drug Testing Players Revenue Share Top 10 and Top 5 in 2025 Figure 22. Players Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 23. Global Drug Testing Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 24. Global Drug Testing Revenue Market Share 2021 VS 2025 VS 2032 Figure 25. Global Drug Testing Revenue Market Share by Type (2021-2032) Figure 26. Global Drug Testing Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 27. Global Drug Testing Revenue Market Share by Application (2021 VS 2025 VS 2032) Figure 28. Global Drug Testing Revenue Market Share by Application (2021-2032) Figure 29. North America Drug Testing Revenue YoY Growth (2021-2032) & (US$ Million) Figure 30. North America Drug Testing Revenue Share by Type (2021-2032) Figure 31. North America Drug Testing Revenue Share by Application (2021-2032) Figure 32. North America Drug Testing Revenue Share by Country (2021-2032) Figure 33. United States Drug Testing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 34. Canada Drug Testing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 35. Mexico Drug Testing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 36. Europe Drug Testing Revenue YoY Growth (2021-2032) & (US$ Million) Figure 37. Europe Drug Testing Revenue Share by Type (2021-2032) Figure 38. Europe Drug Testing Revenue Share by Application (2021-2032) Figure 39. Europe Drug Testing Revenue Share by Country (2021-2032) Figure 40. Germany Drug Testing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 41. France Drug Testing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 42. U.K. Drug Testing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 43. Italy Drug Testing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 44. Spain Drug Testing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 45. Russia Drug Testing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 46. Netherlands Drug Testing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 47. Nordic Countries Drug Testing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 48. China Drug Testing Revenue YoY Growth (2021-2032) & (US$ Million) Figure 49. China Drug Testing Revenue Share by Type (2021-2032) Figure 50. China Drug Testing Revenue Share by Application (2021-2032) Figure 51. Asia Drug Testing Revenue YoY Growth (2021-2032) & (US$ Million) Figure 52. Asia Drug Testing Revenue Share by Type (2021-2032) Figure 53. Asia Drug Testing Revenue Share by Application (2021-2032) Figure 54. Asia Drug Testing Revenue Share by Region (2021-2032) Figure 55. Japan Drug Testing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 56. South Korea Drug Testing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 57. India Drug Testing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 58. Australia Drug Testing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 59. Taiwan Drug Testing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 60. Southeast Asia Drug Testing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 61. SAMEA Drug Testing Revenue YoY Growth (2021-2032) & (US$ Million) Figure 62. SAMEA Drug Testing Revenue Share by Type (2021-2032) Figure 63. SAMEA Drug Testing Revenue Share by Application (2021-2032) Figure 64. SAMEA Drug Testing Revenue Share by Country (2021-2032) Figure 65. Brazil Drug Testing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 66. Argentina Drug Testing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 67. Chile Drug Testing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 68. Colombia Drug Testing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 69. Peru Drug Testing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 70. Saudi Arabia Drug Testing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 71. Israel Drug Testing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 72. UAE Drug Testing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 73. Turkey Drug Testing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 74. Iran Drug Testing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 75. Egypt Drug Testing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 76. Years Considered Figure 77. Research Process Figure 78. Key Executives Interviewed

Scope & coverage.

Types
  • Hair Sample
  • Breath Sample
  • Oral Fluid
  • Urine Sample
  • Others
Applications
  • Personal Users
  • Workplace and Schools
  • Pain Management Centers
  • Criminal Justice System & Law Enforcement Agencies
  • Drug Testing Laboratories
  • Drug Treatment Centers
  • Hospitals
Companies covered
  • Siemens Healthcare
  • Thermo Fisher Scientific
  • Roche Diagnostics
  • Quest Diagnostics
  • Shimadzu
  • Quest Diagnostics
  • Laboratory Corporation of America MPD
  • KGAA Alere
  • Express Diagnostics
  • Drgerwerk AG & Co.

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Drug Testing Market by Type
  3. 1.2.1 Global Drug Testing Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Hair Sample
  5. 1.2.3 Breath Sample
  6. 1.2.4 Oral Fluid
  7. 1.2.5 Urine Sample
  8. 1.2.6 Others
  9. 1.3 Drug Testing Market by Application
  10. 1.3.1 Global Drug Testing Market Size by Application, 2021 VS 2025 VS 2032
  11. 1.3.2 Personal Users
  12. 1.3.3 Workplace and Schools
  13. 1.3.4 Pain Management Centers
  14. 1.3.5 Criminal Justice System & Law Enforcement Agencies
  15. 1.3.6 Drug Testing Laboratories
  16. 1.3.7 Drug Treatment Centers
  17. 1.3.8 Hospitals
  18. 1.4 Assumptions and Limitations
  19. 1.5 Study Goals and Objectives
2 Drug Testing Market Dynamics
  1. 2.1 Drug Testing Industry Trends
  2. 2.2 Drug Testing Industry Drivers
  3. 2.3 Drug Testing Industry Opportunities and Challenges
  4. 2.4 Drug Testing Industry Restraints
3 Global Growth Perspective
  1. 3.1 Global Drug Testing Market Perspective (2021-2032)
  2. 3.2 Global Drug Testing Growth Trends by Region
  3. 3.2.1 Global Drug Testing Market Size by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Drug Testing Market Size by Region (2021-2026)
  5. 3.2.3 Global Drug Testing Market Size by Region (2027-2032)
4 Competitive Landscape by Players
  1. 4.1 Global Drug Testing Revenue by Players
  2. 4.1.1 Global Drug Testing Revenue by Players (2021-2026)
  3. 4.1.2 Global Drug Testing Revenue Market Share by Players (2021-2026)
  4. 4.1.3 Global Drug Testing Players Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Drug Testing Key Players Ranking, 2024 VS 2025 VS 2026
  6. 4.3 Global Drug Testing Key Players Headquarters & Area Served
  7. 4.4 Global Drug Testing Players, Product Type & Application
  8. 4.5 Global Drug Testing Players Establishment Date
  9. 4.6 Market Competitive Analysis
  10. 4.6.1 Global Drug Testing Market CR5 and HHI
  11. 4.6.3 2025 Drug Testing Tier 1, Tier 2, and Tier 3
5 Drug Testing Market Size by Type
  1. 5.1 Global Drug Testing Revenue by Type (2021 VS 2025 VS 2032)
  2. 5.2 Global Drug Testing Revenue by Type (2021-2032)
  3. 5.3 Global Drug Testing Revenue Market Share by Type (2021-2032)
6 Drug Testing Market Size by Application
  1. 6.1 Global Drug Testing Revenue by Application (2021 VS 2025 VS 2032)
  2. 6.2 Global Drug Testing Revenue by Application (2021-2032)
  3. 6.3 Global Drug Testing Revenue Market Share by Application (2021-2032)
7 Company Profiles
  1. 7.1 Siemens Healthcare
  2. 7.1.1 Siemens Healthcare Company Information
  3. 7.1.2 Siemens Healthcare Business Overview
  4. 7.1.3 Siemens Healthcare Drug Testing Revenue and Gross Margin (2021-2026)
  5. 7.1.4 Siemens Healthcare Drug Testing Product Portfolio
  6. 7.1.5 Siemens Healthcare Recent Developments
  7. 7.2 Thermo Fisher Scientific
  8. 7.2.1 Thermo Fisher Scientific Company Information
  9. 7.2.2 Thermo Fisher Scientific Business Overview
  10. 7.2.3 Thermo Fisher Scientific Drug Testing Revenue and Gross Margin (2021-2026)
  11. 7.2.4 Thermo Fisher Scientific Drug Testing Product Portfolio
  12. 7.2.5 Thermo Fisher Scientific Recent Developments
  13. 7.3 Roche Diagnostics
  14. 7.3.1 Roche Diagnostics Company Information
  15. 7.3.2 Roche Diagnostics Business Overview
  16. 7.3.3 Roche Diagnostics Drug Testing Revenue and Gross Margin (2021-2026)
  17. 7.3.4 Roche Diagnostics Drug Testing Product Portfolio
  18. 7.3.5 Roche Diagnostics Recent Developments
  19. 7.4 Quest Diagnostics
  20. 7.4.1 Quest Diagnostics Company Information
  21. 7.4.2 Quest Diagnostics Business Overview
  22. 7.4.3 Quest Diagnostics Drug Testing Revenue and Gross Margin (2021-2026)
  23. 7.4.4 Quest Diagnostics Drug Testing Product Portfolio
  24. 7.4.5 Quest Diagnostics Recent Developments
  25. 7.5 Shimadzu
  26. 7.5.1 Shimadzu Company Information
  27. 7.5.2 Shimadzu Business Overview
  28. 7.5.3 Shimadzu Drug Testing Revenue and Gross Margin (2021-2026)
  29. 7.5.4 Shimadzu Drug Testing Product Portfolio
  30. 7.5.5 Shimadzu Recent Developments
  31. 7.6 Quest Diagnostics
  32. 7.6.1 Quest Diagnostics Company Information
  33. 7.6.2 Quest Diagnostics Business Overview
  34. 7.6.3 Quest Diagnostics Drug Testing Revenue and Gross Margin (2021-2026)
  35. 7.6.4 Quest Diagnostics Drug Testing Product Portfolio
  36. 7.6.5 Quest Diagnostics Recent Developments
  37. 7.7 Laboratory Corporation of America MPD
  38. 7.7.1 Laboratory Corporation of America MPD Company Information
  39. 7.7.2 Laboratory Corporation of America MPD Business Overview
  40. 7.7.3 Laboratory Corporation of America MPD Drug Testing Revenue and Gross Margin (2021-2026)
  41. 7.7.4 Laboratory Corporation of America MPD Drug Testing Product Portfolio
  42. 7.7.5 Laboratory Corporation of America MPD Recent Developments
  43. 7.8 KGAA Alere
  44. 7.8.1 KGAA Alere Company Information
  45. 7.8.2 KGAA Alere Business Overview
  46. 7.8.3 KGAA Alere Drug Testing Revenue and Gross Margin (2021-2026)
  47. 7.8.4 KGAA Alere Drug Testing Product Portfolio
  48. 7.8.5 KGAA Alere Recent Developments
  49. 7.9 Express Diagnostics
  50. 7.9.1 Express Diagnostics Company Information
  51. 7.9.2 Express Diagnostics Business Overview
  52. 7.9.3 Express Diagnostics Drug Testing Revenue and Gross Margin (2021-2026)
  53. 7.9.4 Express Diagnostics Drug Testing Product Portfolio
  54. 7.9.5 Express Diagnostics Recent Developments
  55. 7.10 Drgerwerk AG & Co.
  56. 7.10.1 Drgerwerk AG & Co. Company Information
  57. 7.10.2 Drgerwerk AG & Co. Business Overview
  58. 7.10.3 Drgerwerk AG & Co. Drug Testing Revenue and Gross Margin (2021-2026)
  59. 7.10.4 Drgerwerk AG & Co. Drug Testing Product Portfolio
  60. 7.10.5 Drgerwerk AG & Co. Recent Developments
8 North America
  1. 8.1 North America Drug Testing Revenue (2021-2032)
  2. 8.2 North America Drug Testing Revenue by Type (2021-2032)
  3. 8.2.1 North America Drug Testing Revenue by Type (2021-2026)
  4. 8.2.2 North America Drug Testing Revenue by Type (2027-2032)
  5. 8.3 North America Drug Testing Revenue Share by Type (2021-2032)
  6. 8.4 North America Drug Testing Revenue by Application (2021-2032)
  7. 8.4.1 North America Drug Testing Revenue by Application (2021-2026)
  8. 8.4.2 North America Drug Testing Revenue by Application (2027-2032)
  9. 8.5 North America Drug Testing Revenue Share by Application (2021-2032)
  10. 8.6 North America Drug Testing Revenue by Country
  11. 8.6.1 North America Drug Testing Revenue by Country (2021 VS 2025 VS 2032)
  12. 8.6.2 North America Drug Testing Revenue by Country (2021-2026)
  13. 8.6.3 North America Drug Testing Revenue by Country (2027-2032)
  14. 8.6.4 United States
  15. 8.6.5 Canada
9 Europe
  1. 9.1 Europe Drug Testing Revenue (2021-2032)
  2. 9.2 Europe Drug Testing Revenue by Type (2021-2032)
  3. 9.2.1 Europe Drug Testing Revenue by Type (2021-2026)
  4. 9.2.2 Europe Drug Testing Revenue by Type (2027-2032)
  5. 9.3 Europe Drug Testing Revenue Share by Type (2021-2032)
  6. 9.4 Europe Drug Testing Revenue by Application (2021-2032)
  7. 9.4.1 Europe Drug Testing Revenue by Application (2021-2026)
  8. 9.4.2 Europe Drug Testing Revenue by Application (2027-2032)
  9. 9.5 Europe Drug Testing Revenue Share by Application (2021-2032)
  10. 9.6 Europe Drug Testing Revenue by Country
  11. 9.6.1 Europe Drug Testing Revenue by Country (2021 VS 2025 VS 2032)
  12. 9.6.2 Europe Drug Testing Revenue by Country (2021-2026)
  13. 9.6.3 Europe Drug Testing Revenue by Country (2027-2032)
  14. 9.6.4 Germany
  15. 9.6.5 France
  16. 9.6.6 U.K.
  17. 9.6.7 Italy
  18. 9.6.8 Netherlands
10 China
  1. 10.1 China Drug Testing Revenue (2021-2032)
  2. 10.2 China Drug Testing Revenue by Type (2021-2032)
  3. 10.2.1 China Drug Testing Revenue by Type (2021-2026)
  4. 10.2.2 China Drug Testing Revenue by Type (2027-2032)
  5. 10.3 China Drug Testing Revenue Share by Type (2021-2032)
  6. 10.4 China Drug Testing Revenue by Application (2021-2032)
  7. 10.4.1 China Drug Testing Revenue by Application (2021-2026)
  8. 10.4.2 China Drug Testing Revenue by Application (2027-2032)
  9. 10.5 China Drug Testing Revenue Share by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Drug Testing Revenue (2021-2032)
  2. 11.2 Asia Drug Testing Revenue by Type (2021-2032)
  3. 11.2.1 Asia Drug Testing Revenue by Type (2021-2026)
  4. 11.2.2 Asia Drug Testing Revenue by Type (2027-2032)
  5. 11.3 Asia Drug Testing Revenue Share by Type (2021-2032)
  6. 11.4 Asia Drug Testing Revenue by Application (2021-2032)
  7. 11.4.1 Asia Drug Testing Revenue by Application (2021-2026)
  8. 11.4.2 Asia Drug Testing Revenue by Application (2027-2032)
  9. 11.5 Asia Drug Testing Revenue Share by Application (2021-2032)
  10. 11.6 Asia Drug Testing Revenue by Country
  11. 11.6.1 Asia Drug Testing Revenue by Country (2021 VS 2025 VS 2032)
  12. 11.6.2 Asia Drug Testing Revenue by Country (2021-2026)
  13. 11.6.3 Asia Drug Testing Revenue by Country (2027-2032)
  14. 11.6.4 Japan
  15. 11.6.5 South Korea
  16. 11.6.6 India
  17. 11.6.7 Australia
  18. 11.6.8 Taiwan
  19. 11.6.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Drug Testing Revenue (2021-2032)
  2. 12.2 SAMEA Drug Testing Revenue by Type (2021-2032)
  3. 12.2.1 SAMEA Drug Testing Revenue by Type (2021-2026)
  4. 12.2.2 SAMEA Drug Testing Revenue by Type (2027-2032)
  5. 12.3 SAMEA Drug Testing Revenue Share by Type (2021-2032)
  6. 12.4 SAMEA Drug Testing Revenue by Application (2021-2032)
  7. 12.4.1 SAMEA Drug Testing Revenue by Application (2021-2026)
  8. 12.4.2 SAMEA Drug Testing Revenue by Application (2027-2032)
  9. 12.5 SAMEA Drug Testing Revenue Share by Application (2021-2032)
  10. 12.6 SAMEA Drug Testing Revenue by Country
  11. 12.6.1 SAMEA Drug Testing Revenue by Country (2021 VS 2025 VS 2032)
  12. 12.6.2 SAMEA Drug Testing Revenue by Country (2021-2026)
  13. 12.6.3 SAMEA Drug Testing Revenue by Country (2027-2032)
  14. 12.6.4 Brazil
  15. 12.6.5 Argentina
  16. 12.6.6 Chile
  17. 12.6.7 Colombia
  18. 12.6.8 Peru
  19. 12.6.9 Saudi Arabia
  20. 12.6.10 Israel
  21. 12.6.11 UAE
  22. 12.6.12 Turkey
  23. 12.6.13 Iran
  24. 12.6.14 Egypt
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst